Vaishali Pharma Limited

NSE VAISHALI.NS

Vaishali Pharma Limited EBIT Margin for the year ending March 31, 2024: 3.09%

Vaishali Pharma Limited EBIT Margin is 3.09% for the year ending March 31, 2024, a -80.19% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Vaishali Pharma Limited EBIT Margin for the year ending March 31, 2023 was 15.58%, a 36.15% change year over year.
  • Vaishali Pharma Limited EBIT Margin for the year ending March 31, 2022 was 11.44%, a 49.09% change year over year.
  • Vaishali Pharma Limited EBIT Margin for the year ending March 31, 2021 was 7.68%, a 75.11% change year over year.
  • Vaishali Pharma Limited EBIT Margin for the year ending March 31, 2020 was 4.38%, a -15.78% change year over year.
Key data
Date EBIT Margin EPS (Basic) EPS (Diluted) Shares (Basic, Weighted)
Market news
Loading...
SV Wall Street
NSE: VAISHALI.NS

Vaishali Pharma Limited

CEO Mr. Hemanth Damodar Pathak
IPO Date Aug. 22, 2017
Location India
Headquarters 706 to 709, Aravalli Business Center
Employees 27
Sector Healthcare
Industries
Description

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.

Similar companies

KREBSBIO.NS

Krebs Biochemicals & Industries Limited

USD 1.15

4.92%

ZOTA.NS

Zota Health Care Limited

USD 10.92

-0.24%

ALBERTDAVD.NS

Albert David Limited

USD 13.52

1.95%

BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited

USD 0.64

5.12%

StockViz Staff

February 2, 2025

Any question? Send us an email